Is the 2013 American Thoracic Society CPAP-tracking system algorithm useful for managing non-adherence in long-term CPAP-treated patients?


Journal

Respiratory research
ISSN: 1465-993X
Titre abrégé: Respir Res
Pays: England
ID NLM: 101090633

Informations de publication

Date de publication:
12 Sep 2019
Historique:
received: 08 05 2019
accepted: 31 07 2019
entrez: 14 9 2019
pubmed: 14 9 2019
medline: 29 2 2020
Statut: epublish

Résumé

Whereas telemedicine usage is growing, the only clinical algorithm for Continuous Positive Airway Pressure (CPAP) adherence management is that stipulated by the 2013 American Thoracic Society (ATS). The capacity of the latter to predict non-adherence in long-term CPAP-treated patients has not been validated. Patients from the prospective real-life InterfaceVent study (NCT03013283, study conducted in an adult cohort undergoing at least 3 months of CPAP) and eligible for ATS algorithm usage were analysed. The residual device Apnea-Hypopnea-Index (AHI 650/1484 patients eligible for ATS algorithm usage were analysed (15.38% non-adherent, 74% male with a median (IQ When managing non-adherence in long-term CPAP-treated patients, our data do not validate absolute AHI The INTERFACE-VENT study is registered on ClinicalTrials.gov (Identifier: study ( NCT03013283 ).

Sections du résumé

BACKGROUND BACKGROUND
Whereas telemedicine usage is growing, the only clinical algorithm for Continuous Positive Airway Pressure (CPAP) adherence management is that stipulated by the 2013 American Thoracic Society (ATS). The capacity of the latter to predict non-adherence in long-term CPAP-treated patients has not been validated.
METHODS METHODS
Patients from the prospective real-life InterfaceVent study (NCT03013283, study conducted in an adult cohort undergoing at least 3 months of CPAP) and eligible for ATS algorithm usage were analysed. The residual device Apnea-Hypopnea-Index (AHI
RESULTS RESULTS
650/1484 patients eligible for ATS algorithm usage were analysed (15.38% non-adherent, 74% male with a median (IQ
CONCLUSION CONCLUSIONS
When managing non-adherence in long-term CPAP-treated patients, our data do not validate absolute AHI
TRIAL REGISTRATION BACKGROUND
The INTERFACE-VENT study is registered on ClinicalTrials.gov (Identifier: study ( NCT03013283 ).

Identifiants

pubmed: 31514751
doi: 10.1186/s12931-019-1150-7
pii: 10.1186/s12931-019-1150-7
pmc: PMC6739917
doi:

Types de publication

Letter

Langues

eng

Sous-ensembles de citation

IM

Pagination

209

Références

Chest. 2001 Feb;119(2):460-5
pubmed: 11171723
Chest. 2004 Oct;126(4):1248-54
pubmed: 15486389
Respir Care. 2011 May;56(5):591-5
pubmed: 21276319
Sleep. 2011 Jun 01;34(6):801-6
pubmed: 21629369
Sleep. 2012 Sep 01;35(9):1277-83A
pubmed: 22942506
Am J Respir Crit Care Med. 2013 Sep 1;188(5):613-20
pubmed: 23992588
Thorax. 2015 Mar;70(3):284-5
pubmed: 25582449
J Clin Sleep Med. 2016 Aug 15;12(8):1153-8
pubmed: 27166303
JAMA. 2017 Jul 11;318(2):156-166
pubmed: 28697252
Chest. 2018 Apr;153(4):834-842
pubmed: 28847549
Am J Respir Crit Care Med. 2018 Jan 1;197(1):117-126
pubmed: 28858567
Chest. 2018 Apr;153(4):774-775
pubmed: 29626967

Auteurs

Marie-Caroline Rotty (MC)

IMAG, CNRS, Montpellier University, Montpellier University Hospital, Montpellier, France.
Apard groupe Adène, Montpellier, France.

Jean-Pierre Mallet (JP)

Department of Respiratory Diseases, Montpellier University Hospital, Arnaud de Villeneuve Hospital, 371, Avenue Doyen Giraud, 34295, Montpellier Cedex 5, France.

Carey M Suehs (CM)

Department of Respiratory Diseases, Montpellier University Hospital, Arnaud de Villeneuve Hospital, 371, Avenue Doyen Giraud, 34295, Montpellier Cedex 5, France.
Department of Medical Information, Montpellier University Hospital, Montpellier, France.

Christian Martinez (C)

Apard groupe Adène, Montpellier, France.

Jean-Christian Borel (JC)

Grenoble Alps University, Inserm U1042, HP2 (Hypoxia PhysioPathology) Laboratory, Centre Hospitalier Universitaire Grenoble Alpes, Grenoble, France.

Claudio Rabec (C)

Pulmonary Department and Respiratory Critical Care Unit, University Hospital Dijon, Dijon, France.

Arnaud Bourdin (A)

Department of Respiratory Diseases, Montpellier University Hospital, Arnaud de Villeneuve Hospital, 371, Avenue Doyen Giraud, 34295, Montpellier Cedex 5, France.
PhyMedExp (INSERM U 1046, CNRS UMR9214), Montpellier University, Montpellier, France.

Nicolas Molinari (N)

IMAG, CNRS, Montpellier University, Montpellier University Hospital, Montpellier, France.
Department of Medical Information, Montpellier University Hospital, Montpellier, France.

Dany Jaffuel (D)

Department of Respiratory Diseases, Montpellier University Hospital, Arnaud de Villeneuve Hospital, 371, Avenue Doyen Giraud, 34295, Montpellier Cedex 5, France. dany.jaffuel@wanadoo.fr.
Pulmonary Disorders and Respiratory Sleep Disorders Unit, Polyclinic Saint-Privat, Boujan sur Libron, France. dany.jaffuel@wanadoo.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH